ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 6 2023 03:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 5 2023 13:01:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 5 2023 03:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 5 2023 13:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 3 2023 13:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 3 2023 03:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 3 2023 13:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 1 2023 03:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 11 2022 13:05:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 11 2022 13:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 10 2022 03:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 9 2022 06:00:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 8 2022 13:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 8 2022 13:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 8 2022 05:00:02 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 7 2022 04:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Sale of Hospital Products

24 6 2022 04:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2022 Financial Results

12 5 2022 13:02:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

03 5 2022 13:02:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

11 4 2022 13:01:00 提供 Nasdaq GlobeNewswire